1. Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
3. Market Analysis
3.1 Overview
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analysis
4. Market Dynamics
4.1 Drivers
4.1.1 Increasing focus on drug discovery
4.1.2 Rising R&D Expenditure
4.1.3 Need to control drug discovery and development costs
4.2 Restraints
4.2.1 Increase in setup cost of informative software
4.2.2 Lack of data availability
4.3 Opportunities
4.3.1 Growth in the biotechnology industry
4.3.2 Patent expiry
4.4 Challenges
4.4.1 Scarcity of skilled professionals
5. North America Drug Discovery Informatics Market - By Function
5.1 Docking
5.2 Molecular Modelling
5.3 Sequencing and Target Data Analysis
5.4 Libraries and Database Preparation
5.5 Others
6. North America Drug Discovery Informatics Market - By Solution
6.1 Software
6.2 Services
7. North America Drug Discovery Informatics Market - By End-User
7.1 Pharmaceutical and Biotechnology Companies
7.2 Contract Research Organizations
7.3 Other End-Users
8. North America Drug Discovery Informatics Market – By Geography
8.1 Introduction
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.2.4 Rest of North America
9. North America Drug Discovery Informatics Market – By Company Profiles
9.1 Collaborative drug discovery
9.2 GVK Biosciences
9.3 Drug Development Informatics
9.4 Selvita
9.5 Charles River Laboratories
9.6. Certara Pharma
9.7 Open Eye Scientific Software
9.8 Cortellis Informatics
9.9 Infosys
9.10 PerkinElmer
10. North America Drug Discovery Informatics Market – By Competitive Landscape
10.1. Market Share Analysis
10.2. Strategies Adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
11. Market Insights
11.1 Insights of Industry Experts
11.2 Analyst Opinion (Market Understanding)
11.3 Investment Opportunities
12. Appendix
12.1 List of Tables
12.2 List of Figures
